Plasma Fractionation Market Worth $36.7 Billion by 2027 - Exclusive Report by MarketsandMarkets™
In August 2021, CSL (Australia) Received FDA approval for the new BERINERT [C1 Esterase inhibitor, Human (Intravenous)] Administration Kit for improved patient convenience.
View full press release